Carlsmed Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Income StatementBalance SheetCash FlowRatios
Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Carlsmed, Inc. (CARL) - Annual data in millions USD
BreakdownFY 2024FY 2023
Period EndingDec 2024Dec 2023
Operating Activities
Net Income-24.26-18.90
Depreciation & Amortization0.150.14
Stock Based Compensation0.250.12
Change in Working Capital-4.08-0.89
Change in Accounts Receivable-3.97-2.43
Change in Inventory-1.80-0.91
Change in Accounts Payable0.300.94
Change in Other Working Capital1.390.55
Other Operating Activities2.100.55
Net Cash from Operating Activities-25.47-17.48
Investing Activities
Capital Expenditures-0.18-0.14
Net Cash from Investing Activities-0.18-0.14
Financing Activities
Debt Repayment6.210.00
Common Stock Issued0.030.06
Other Financing Activities-0.250.00
Net Cash from Financing Activities58.503.18
Summary
Net Change in Cash32.85-14.44
Cash at Beginning of Period7.3721.81
Cash at End of Period40.237.37
Free Cash Flow-25.65-17.62
Supplemental Disclosures
Interest Paid1.120.52